Back to JNJ
ACR Alpine Capital Research, LLC → JNJ
ACR Alpine Capital Research, LLC JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
8
Latest value
$492.8M
Q3 2026
Peak value
$492.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $406.3M |
| Q4 2025 | $56.6M |
| Q1 2026 | $66.5M |
| Q1 2026 | $460.9M |
| Q2 2026 | $476.3M |
| Q2 2026 | $68.8M |
| Q3 2026 | $71.6M |
| Q3 2026 | $492.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $492.8M | 1.86M | — | — |
| Q3 2026 | $71.6M | 270.4K | — | — |
| Q2 2026 | $68.8M | 270.9K | — | — |
| Q2 2026 | $476.3M | 1.88M | — | — |
| Q1 2026 | $460.9M | 1.89M | — | — |
| Q1 2026 | $66.5M | 271.9K | — | — |
| Q4 2025 | $56.6M | 273.6K | — | — |
| Q4 2025 | $406.3M | 1.96M | — | — |
Other funds holding JNJ
$44.8B
$39.6B
$34.5B
$32.6B
$27.7B